U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06838143) titled 'Ilaris NIS in Korea' on Feb. 14.
Brief Summary: This is a study to evaluate safety and effectiveness of Ilaris in adult and pediatric patients receiving the drug in a clinical setting for any of the following indications, Hereditary Periodic Fever Syndromes, Cryopyrin-associated periodic syndromes (CAPS), colchicine resistance familial Mediterranean fever (crFMF), TNF receptor associated periodic syndrome (TRAPS), Hyper-IgD syndrome / Mevalonate kinase deficiency (HIDS/MKD) or Systemic juvenile idiopathic arthritis (sJIA).
Study Start Date: Feb. 28
Study Type: OBSERVATIONAL
Condition:
Hereditary Periodic Fever Syndromes
Cryopyri...